Cargando…
A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism
Multiple myeloma (MM) is a disease caused by malignant plasma cells, causing free light chain release accompanying the increase in monoclonal immunoglobulin. Cytochrome P450 (CYP) is one of the large and functional enzyme families composed of various hemoproteins. This protein network has been shown...
Autores principales: | Serin, Istemi, Pehlivan, Sacide, Gundes, Ilknur, Fidan Oyaci, Yasemin, Pehlivan, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653211/ https://www.ncbi.nlm.nih.gov/pubmed/33170343 http://dx.doi.org/10.1007/s00277-020-04339-1 |
Ejemplares similares
-
What are the roles of global DNA and APC 2 gene promotor hypermethylation in multiple myeloma?
por: Pehlivan, Sacide, et al.
Publicado: (2021) -
Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma
por: Tuncel, Fatıma Ceren, et al.
Publicado: (2022) -
PB2075: HOW EFFECTIVE ARE LEPTIN GENE POLYMORPHISMS AND METHYLATION DURING THE COURSE OF MULTIPLE MYELOMA (MM)?
por: Serin, Istemi, et al.
Publicado: (2023) -
The miRNA 196a2 rs11614913 variant has prognostic impact on Turkish patients with multiple myeloma
por: Kirik, Melya Pelin, et al.
Publicado: (2020) -
Effect of the uncoupling protein-2 (UCP-2) and nuclear receptor subfamily 3 group C member 1 (NR3C1) genes on treatment efficacy and survival in patients with multiple myeloma: a single-center study
por: Demir, Ilknur, et al.
Publicado: (2021)